176 trials (keyword fallback)
Hemorrhoids, Internal
Primary: Number of Participants With Resolution of Symptoms — 18 participants
Hemorrhoids · Hemorrhoidal Disease
Primary: Hemorrhoid Regression Rate — 117; 33 Participants — p=<0.001
Internal Hemorrhoids
Primary: Reduction in Swelling — 2.3; 2.0 scores on a scale — p=0.8918
Hemorrhoids
Primary: Intraoperative Bleeding — 32; 50 participants — p=0.0001
Hemorrhoids Third Degree
Primary: Hemorrhoidal Disease Symptom Score — 1; 7 units on a scale
Lung Cancer
Primary: Time to Local Recurrence — NA; NA years — p=0.98
Thumb Carpometacarpal Osteoarthritis
Primary: Postoperative Follow-Up Retention Rate — 17; 13; 0; 2 thumbs
Jaw, Edentulous · Dental Implant
Primary: Comparison of Quantitative Bone Healing — -1.18; -1.01; -0.91 mm — p=<0.05
Jugular Venous Blood Flow
Primary: Internal Jugular Venous (IJV) Cross Sectional Area — 1.2; 1.0; 1.8; 1.4 cm2
Prostate Cancer
Primary: Treatment Tolerance (Genitourinary [GU] or Gastrointestinal [GI] Adverse Events) — 3 events
Prostate Cancer
Primary: Number of Patients With an Acceptable Level of Severe Toxicity as Defined at < Grade 3 CTC Toxicity — 20 participants
Post Operative Pain · Recurrence
Primary: Number of Participants With Recurrence of Disease or Fistula — 5; 10 Participants
Knee Instability
Primary: Static Knee Stability
Surgical Remove of Hemorrhoids
Primary: Measurement of Time to Start the Anaesthetic Effect — 2.1; 1.6; 7.7; 4.7 minutes
Hemorrhoids
Primary: Changes in the Quality of Life of Patients Suffering From Acute or Chronic Hemorrhoids Within 1 Month After Presenting to a Doctor (Visit V0 vs Visit3) — 16.5; 11.1…